The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
Strengthening focus in Alzheimer's disease and neuroscience pipeline
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Granules now has a total of 67 ANDA approvals from the USFDA
Subscribe To Our Newsletter & Stay Updated